US HB8987 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on December 16 2020 - 25% progression, died in committee
Action: 2020-12-16 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on December 16 2020 - 25% progression, died in committee
Action: 2020-12-16 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Public Health Service Act to incentivize the manufacture of certain medicines in the United States and to enhance the security of the United States pharmaceutical supply chain, and for other purposes.
Title
Enhancing the Security of the U.S. Pharmaceutical Supply Chain Act of 2020
Sponsors
| Rep. John Joyce [R-PA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2020-12-16 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2020-12-16 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2020-12-16 | House | Introduced in House |
Subjects
Business expenses
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Emergency medical services and trauma care
Executive agency funding and structure
Health
Health promotion and preventive care
Income tax credits
Infectious and parasitic diseases
Manufacturing
Medical tests and diagnostic methods
Public contracts and procurement
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Emergency medical services and trauma care
Executive agency funding and structure
Health
Health promotion and preventive care
Income tax credits
Infectious and parasitic diseases
Manufacturing
Medical tests and diagnostic methods
Public contracts and procurement
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/8987/all-info |
| Text | https://www.congress.gov/116/bills/hr8987/BILLS-116hr8987ih.pdf |
